Clinical Trial Update: Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 trial from the University of Vermont investigates fecal microbiota transplant for active moderate Ulcerative Colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: University of Vermont | Conditions: Ulcerative Colitis, Active Moderate | EARLY_Phase 1 | Status: UNKNOWN